Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 89 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Case Report: A Case of First-Line Treatment for Rare ROS1 Fusion Mutation Lung Adenocarcinoma with Entrectinib
Yifan Yang, Qing Yi, Wei Yang,Yongzhong Luo,Lemeng Zhang
Frontiers in oncology (2025): 1566687-1566687
Cited0Views0WOSBibtex
0
0
Enhancing Clinical Precision in Lung Cancer Tissue Biopsy Through Elevated Response-Threshold of an Endoplasmic Reticulum-Targeted Fluorogenic Probe
Zhiyang Yuwen, Xinglong Chen, Kexin Chen, Tenglong Zou,Guojiang Mao,Hongwen Liu,Lemeng Zhang
Materials today Bio (2025): 101654-101654
Cited0Views0WOSBibtex
0
0
MACC1 is a Potential Prognostic Biomarker for Cancer Immunotherapy in Lung Adenocarcinoma
Changqie Pan, Zhiyuan Zhou, Jun Cao,Lemeng Zhang, Tianli Cheng,Haitao Li, Zhou Jiang,Danhui Huang, Dongqiang Zeng,Yongzhong Luo, Jianhua Wu
Carcinogenesisno. 2 (2025)
Cited0Views0WOSBibtex
0
0
Research Progress on Novel Antibody Drug Conjugates in Cancer Therapy
Yuning Li, Jialin Su,Shuhua Tan,Yongzhong Luo,Lemeng Zhang
Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciencesno. 2 (2024): 296-304
Cited0Views0WOSBibtex
0
0
Clinical Significance and Biological Function of Interferon Regulatory Factor 1 in Non-Small Cell Lung Cancer
Jialin Su,Shuhua Tan, Yuning Li, Xinglong Chen, Jiasi Liu,Yongzhong Luo,Changqie Pan,Lemeng Zhang
Frontiers in Pharmacology (2024)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 90

#Citation: 2672

H-Index: 24

G-Index: 51

Sociability: 6

Diversity: 3

Activity: 21

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn